Delivering Excellence in International Markets
Blue Cross Laboratories has established itself as a leading player in the global pharmaceutical industry, driven by its commitment to quality, innovation, and regulatory excellence. With world-class manufacturing facilities in Nasik and Goa, accredited by multiple international health authorities, we ensure that our products meet the highest global standards. Our ability to produce liquid, solid, and semi-solid dosage forms allows us to cater to diverse therapeutic needs while maintaining consistency in quality and efficacy.
Our expanding international presence is a testament to our dedication to making high-quality and affordable medicines accessible across continents. We offer a broad range of branded generics spanning Pain and Spasm Management, Gastrointestinal Disorders, Cardiovascular Disease Management, Anti-infectives, Respiratory Health, Diabetes Care, and Dermatology. This extensive portfolio allows us to address pressing healthcare challenges in both emerging and developed markets.
Currently, Our manufacturing facilities are accredited by leading regulatory authorities, including the National Drug Authority (NDA) – Uganda, Tanzania Medicines and Medical Devices Authority (TMDA) – Tanzania, Ministry of Health (MOH) – Kenya, Rwanda Food and Drugs Authority (RFDA) – Rwanda, and Ministry of Health (MOH) – DR Congo. Additionally, we are in the process of obtaining approvals from several other African and Asian Countries Regulatory Approvals & other stringent regulatory authorities (SRA countries).
With a strong market presence across Asia and Africa, we export to Kenya, Tanzania, Uganda, Rwanda, D.R. Congo, Mauritius, Maldives, Cambodia, Sri Lanka, Myanmar and Trinidad & Tobago, reinforcing our commitment to delivering high-quality pharmaceutical solutions worldwide. Our strategic partnerships with established distributors and healthcare providers ensure efficient market penetration, product availability, and seamless regulatory compliance. We continue to explore new opportunities in Latin America, the Middle East, and CIS nations, reinforcing our mission to expand our global reach. At the core of our international success lies an unwavering focus on quality and regulatory compliance. Every product manufactured at Blue Cross undergoes rigorous testing and validation to comply with global quality standards, including WHO-GMP, ICH, and stringent national regulatory frameworks. Our state-of-the-art Quality Control and Quality Assurance systems ensure batch-to-batch consistency, while our advanced R&D capabilities enable us to develop innovative formulations that cater to region-specific healthcare needs. Additionally, we are actively expanding into CDMO business opportunities, aiming to serve developed markets with high-quality, compliant pharmaceutical solutions.
Blue Cross Laboratories is not just about producing pharmaceuticals—it is about making a difference in global healthcare. Our team of dedicated professionals, state-of-the-art infrastructure, and strong ethical foundation have fostered a culture of excellence, safety, and continuous improvement. By aligning with international healthcare demands and strengthening our presence in key global markets, we aim to enhance the availability of high-quality medicines and contribute to better health outcomes worldwide.